Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Jan;92(1):51–58. doi: 10.1111/j.1349-7006.2001.tb01047.x

Preclinical in vivo Antitumor Efficacy of Nedaplatin with Gemcitabine against Human Lung Cancer

Mitsunobu Matsumoto 1, Yukihiro Takeda 1, Hideo Maki 1, Kanji Hojo 1, Tohru Wada 1, Yoshinori Nishitani 1, Ryuji Maekawa 1, Takayuki Yoshioka 1,✉
PMCID: PMC5926590  PMID: 11173544

Full Text

The Full Text of this article is available as a PDF (93.4 KB).

References

  • 1.Totani , T. , Aono , K. , Komura , M. . and Adachi , Y.Synthesis of (glycolato‐O, O')diammineplatinum (II) and its related complexes . Chem. Lett. , 3 , 429 – 432 ( 1986. ). [Google Scholar]
  • 2.Suzumura , S. , Kato , T. , Ueda , R. . and Ohta , K.Effect of treatment schedule on antitumor activity of glycolato‐O, O' diammineplatinum (II), a new platinum derivative: comparison with cw‐diamminedichloroplatinum (II) . Anticancer Res. , 9 , 1083 – 1088 ( 1989. ). [PubMed] [Google Scholar]
  • 3.Shiratori , O. , Kasai , H. , Uchida , N. , Takeda , Y. , Totani , T. . and Sato , K.Anti‐tumor activity of 254‐S, a platinum complex, in rodents . In “Recent Advances in Chemotherapy,” ed. Ishigami J. , pp . 635 – 636 ( 1985. ). University of Tokyo Press; , Tokyo . [Google Scholar]
  • 4.Koenuma , M. , Kasai , H. , Uchida , N. , Wada , T. , Hattori , M. , Oguma , T. , Totani , T. . and Inaba , M.Pharmacokinetic correlation between experimental and clinical effects on human non‐small cell lung cancers of cis‐diammine glycolatoplatinum (254‐S) and cis‐diammine dichloroplatinum . Anticancer Res. , 15 , 417 – 422 ( 1995. ). [PubMed] [Google Scholar]
  • 5.Kameyama , Y. , Okazaki , N. , Nakagawa , M. , Koshida , H. , Nakamura , M. . and Gemba , M.Nephrotoxicity of a new platinum compound, 254‐S, evaluated with rat kidney cortical slices . Toxicol. Lett. , 52 , 15 – 24 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 6.Furuse , K. , Fukuoka , M. , Ohshima , S. , Ariyoshi , Y. , Fujii , M. , Kurita , Y. , Hasegawa , K. , Homma , T. , Tamura , M. , Inoue , S. , Nishiwaki , Y. , Kimura , I. . and Niitani , H.Phase II clinical study of (glycolato‐O, O')diammineplatinum (II), a new platinum complex, for primary lung cancer . Proc. Am. Soc. Clin. Oncol. , 8 , 238 ( 1989. ). [Google Scholar]
  • 7.Fukuda , M. , Shinkai , T. , Eguchi , K. , Sasaki , Y. , Tamura , T. , Ohe , Y. , Kojima , A. , Oshita , F. , Hara , K. . and Saijo , N.Phase II study of (glycolato‐O, O')diammineplatinum (II), a novel platinum complex, in the treatment of non‐small‐cell lung cancer . Cancer Chemother. Pharmacol. , 26 , 393 – 396 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 8.Inuyama , Y. , Miyake , H. , Horiuchi , M. , Hayasaki , K. , Komiyama , S. . and Ohta , K.An early phase II study of cis‐diammine glycolato platinum, 254‐S, for head and neck cancers . Jpn. J. Cancer Chemother. , 19 , 863 – 869 ( 1992. ). [PubMed] [Google Scholar]
  • 9.Akaza , H. , Togashi , M. , Nishio , Y. , Miki , T. , Kotake , T. , Matumura , Y. , Yoshida , O. . and Aso , Y.Phase II study of cw‐diammine(glycolato)platinum, 254‐S, in patients with advanced germ‐cell testicular cancer, prostatic cancer, and transitional‐cell carcinoma of the urinary tract . Cancer Chemother. Pharmacol. , 31 , 187 – 192 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 10.Kato , T. , Noda , K. , Hirabayashi , K. . and Nishimura , H.Phase II study of cis‐diammine(glycolato)platinum (254‐S), a new platinum complex, for gynecological malignancy . Proc. 16th Int. Congr. Chemother., Anticancer Sect. , 823 , 1 – 2 ( 1989. ). [Google Scholar]
  • 11.Uchida , N. , Kasai , H. , Takeda , Y. , Maekawa , R. , Sugita , K. . and Yoshioka , T.Augmented antitumor activity in combination chemotherapy of Nedaplatin with Etoposide . Anti-cancer Res. , 18 , 247 – 252 ( 1998. ). [PubMed] [Google Scholar]
  • 12.Takeda , Y. , Kasai , H. , Uchida , N. , Yoshida , H. , Maekawa , R. , Sugita , K. . and Yoshioka , T.Enhanced antitumor efficacy of nedaplatin with 5‐fluorouracil against human squamous carcinoma xenografts . Anticancer Res. , 19 , 4059 – 4064 ( 1999. ). [PubMed] [Google Scholar]
  • 13.Uchida , N. , Yoshida , H. , Yamada , H. , Wada , T. , Daikatsu , K. , Ikeuchi , I. , Maekawa , R. , Sugita , K. . and Yoshioka , T.Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model . Jpn. J. Cancer Res. , 90 , 887 – 894 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Braakhuis , B. J. , Guus , A. M. S. , van Dongen , G. A. , Vermorken , J. B. . and Snow , G. B.Preclinical in vivo activity of 2′,2′‐difluorodeoxycytidine (Gemcitabine) against human head and neck cancer . Cancer Res. , 51 , 211 – 214 ( 1991. ). [PubMed] [Google Scholar]
  • 15.Noble , S. . and Goa , K. L.Gemcitabine. A review of its pharmacology and clinical potential in non‐small cell lung cancer and pancreatic cancer . Drugs , 54 , 447 – 472 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 16.Hui , Y. F. . and Reitz , J.Gemcitabine. A cytidine analogue active against solid tumors . Am. J. Health Syst. Pharm. , 54 , 162 – 170 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 17.Moore , D. F. , Pazdur , R. , Daugherty , K. , Tarassoff , P. . and Abbruzzese , J. L.Phase II study of gemcitabine in advanced colorectal adenocarcinoma . Invest. New Drugs , 10 , 323 – 325 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 18.Casper , E. S. , Green , M. R. , Kelsen , D. P. , Heelan , R. T. , Brown , T. D. , Flombaum , C. D. , Trochanowski , B. . and Tarassoff , P. G.Phase II trial of gemcitabine (2′,2′‐difluo‐rodeoxycytidine) in patients with adenocarcinoma of the pancreas . Invest. New Drugs , 12 , 29 – 34 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 19.Anderson , H. , Lund , B. , Bach , F. , Thatcher , N. , Walling , J. . and Hansen , H. H.Single‐agent activity of weekly gemcitabine in advanced non‐small‐cell lung cancer: a phase II study . J. Clin. Oncol. , 12 , 1821 – 1826 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 20.Cormier , Y. , Eisenhauer , E. , Muldal , A. , Gregg , R. , Ayoub , J. , Goss , G. , Stewart , D. , Tarasoff , P. . and Wong , D.Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group . Ann. Oncol. , 5 , 283 – 285 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 21.Lund , B. , Hansen , O. P. , Theilade , K. , Hansen , M. . and Neijt , J. P.Phase II study of gemcitabine (2′,2′‐difluorode‐oxycytidine) in previously treated ovarian cancer patients . J. Natl. Cancer Inst , 86 , 1530 – 1533 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 22.Michael , M. . and Moore , M.Clinical experience with gemcitabine in pancreatic carcinoma . Oncology , 11 , 1615 – 1622 ( 1997. ). [PubMed] [Google Scholar]
  • 23.Bergman , A. M. , Ruiz van Haperen , V. W. T. , Veerman , G. , Huiper , M. . and Peters , G. J.Synergistic interaction between cisplatin and gemcitabine in vitro . Clin. Cancer Res. , 2 , 521 – 530 ( 1996. ). [PubMed] [Google Scholar]
  • 24.van Moorsel , C. J. A. , Pinedo , H. M. , Veerman , G. , Bergman , A. M. , Kuiper , C. M. , Vermorken , J. B. , van der Vijgh , W. J. F. . and Peters , G. J.Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non‐small‐cell lung cancer cell lines . Br. J. Cancer , 80 , 981 – 990 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Carmichael , J. , Allerheiligen , S. . and Walling , J.Phase I study of gemcitabine and cisplatin in non‐small cell lung cancer . Semin. Oncol , 23 , 55 – 59 ( 1996. ). [PubMed] [Google Scholar]
  • 26.Crino , L. , Scagliotti , G. , Marangolo , M. , Figoli , F. , Clerici , M. , de Marinis , F. , Salvati , F. , Cruciani , G. , Dogliotti , L. , Pucci , F. , Paccagnella , A. , Adamo , V. , Altavilla , G. , Incoronato , P. , Trippetti , M. , Mosconi , A. M. , Santucci , A. , Sorbolini , S. , Oliva , C. . and Tonato , M.Cisplatin‐gemcita‐bine combination in advanced non‐small‐cell lung cancer: a phase II study . J. Clin. Oncol , 15 , 297 – 303 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 27.Mosconi , A. M. , Crino , L. . and Tonato , M.Combination therapy with gemcitabine in non‐small cell lung cancer . Eur. J. Cancer , 33 , S14 – S17 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 28.Anton , A. , Diaz‐Fernandez , N. , Gonzalez Larrba , J. L. , Vadell , C. , Masutti , B. , Montalar , J. , Barneto , L , Artal , A. . and Resell , R.Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non‐small cell lung cancer (NSCLC) . Lung Cancer , 22 , 139 – 148 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 29.Cartei , G. , Sacco , C. , Sibau , A. , Pella , N. , Lop , A. . and Tabaro , G.Cisplatin and gemcitabine in non‐small‐cell lung cancer . Ann. Oncol , 10 , S57 – S62 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 30.Cardenal , F. , Lopex‐Cabrerizo , M. P. , Anton , A. , Alberola , V. , Massuti , B. , Carrato , A. , Barneto , L , Lomas , M. , Garcia , M. , Lianes , P. , Montalar , J. , Vandell , C. , Gonzalez‐Larriba , J. L. , Nguyen , B. , Artal , A. . and Rosell , R.Randomized phase HI study of gemcitabine‐cisplatin versus etoposide‐cisplatin‐etoposide in the treatment of locally advanced or metastatic non‐small‐cell lung cancer . J. Clin. Oncol. , 17 , 12 – 18 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 31.Langer , C. J. , Gandara , D. R. , Calvert , P. , Edelman , M. J. . and Ozols , R. F.Gemcitabine and carboplatin: an update of Phase I and II studies in non‐small cell lung cancer . Semin. Oncol. , 26 , 12 – 18 ( 1999. ). [PubMed] [Google Scholar]
  • 32.Wallenstein , S. , Zucker , C. L. . and Fleis , J. L.Some statistical methods useful in circulation research . Circ. Res. , 47 , 1 – 9 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 33.Dunnett , C. W.New tables for multiple comparisons with a control . Biometrics , 20 , 482 – 491 ( 1964. ). [Google Scholar]
  • 34.Braakhuis , B. J. M. , Ruiz van Haperen , V. W. T. , Welters , M. J. P. . and Peters , G. J.Schedule‐dependent therapeutic efficacy of the combination of gemcitabine and cisplatin in head and neck cancer xenografts . Chem. Eur. J. Cancer , 31A , 2335 – 2340 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 35.van Moorsel , C. J. A. , Pinedo , H. M. , Veerman , G. , Vermorken , J. B. , Postmus , P. E. . and Peters , G. J.Scheduling of gemcitabine and cisplatin in Lewis lung tumour bearing mice . Eur. J. Cancer , 35 , 808 – 814 ( 1999. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES